Gadsden Dialysis is a medicare approved dialysis facility center in Gadsden, Alabama and it has 24 dialysis stations. It is located in Etowah county at 409 South First Street, Gadsden, AL, 35901. You can reach out to the office of Gadsden Dialysis at (256) 547-2457. This dialysis clinic is managed and/or owned by Davita. Gadsden Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 1976. The medicare id for this facility is 012501 and it accepts patients under medicare ESRD program.
| Name | Gadsden Dialysis |
|---|---|
| Location | 409 South First Street, Gadsden, Alabama |
| No. of Dialysis Stations | 24 |
| Medicare ID | 012501 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 409 South First Street, Gadsden, Alabama, 35901 | |
| (256) 547-2457 | |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
| NPI Number | 1215900444 |
| Organization Name | Gadsden Dialysis |
| Doing Business As | Dva Healthcare Renal Care Inc |
| Address | 409 S 1st St Gadsden, Alabama, 35901 |
| Phone Number | (256) 547-2511 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 27 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 22 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 52 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 439 |
| Percentage of adult patients getting regular hemodialysis at the center | 93 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Gadsden Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 456 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 61 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
| Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 44 |
| Patient months included in arterial venous fistula and catheter summaries | 326 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 64 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 12 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 55 |
| Hospitalization Rate in facility | 265.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 438.6 |
| Hospitalization Rate: Lower Confidence Limit | 166 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at Gadsden Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 28.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 39.1 |
| Readmission Rate: Lower Confidence Limit | 19.4 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Gadsden Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 2.58 (Worse than Expected) |
| SIR: Upper Confidence Limit | 4.48 |
| SIR: Lower Confidence Limit | 1.36 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Gadsden Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 48 |
| Transfusion Rate in facility | 128.3 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 231.2 |
| Transfusion Rate: Lower Confidence Limit | 76.5 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
The rate of mortality show you whether patients who were being treated regularly at Gadsden Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 296 |
| Mortality Rate in facility | 24.8 (Worse than Expected) |
| Mortality Rate: Upper Confidence Limit | 32.4 |
| Mortality Rate: Lower Confidence Limit | 18.6 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago
Fresenius Kidney Care Gadsden Acq, Llc Location: 800 Goodyear Avenue, Gadsden, Alabama, 35903 Phone: (256) 456-1242 |
News Archive
ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Pacira Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved an additional bulk manufacturing suite, referred to as Suite C, for EXPAREL (bupivacaine liposome injectable suspension). The suite is housed at the company's Science Center Campus in San Diego, where EXPAREL is currently manufactured.
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogs.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
A major component of olive oil, hydroxytyrosol, is the subject of a Houston Methodist study of women who are at increased risk of developing breast cancer. The study focuses on the changes in breast density after one year of treatment and is the first of its kind in the United States.
› Verified 8 days ago